Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)

China flag China · Delayed Price · Currency is CNY
7.12
+0.35 (5.17%)
Mar 10, 2026, 3:00 PM CST
26.02%
Market Cap 1.96B
Revenue (ttm) 594.86M
Net Income (ttm) -202.28M
Shares Out 289.04M
EPS (ttm) -0.70
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,395,305
Average Volume 8,951,450
Open 6.91
Previous Close 6.77
Day's Range 6.80 - 7.26
52-Week Range 4.23 - 7.55
Beta 0.34
RSI 55.57
Earnings Date Apr 30, 2026

About Jiangsu Nanfang Medical

Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal, medical proof fabrics, adhesive tapes and bandages, sports protection, first-aid kits, and care products in China and internationally. It offers medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic stretch tapes, corn removal plasters, waterproof adhesive tapes, pain relief patches, kinesiology tapes, surgical tapes, zinc oxide a... [Read more]

Sector Healthcare
Founded 1990
Employees 850
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603880
Full Company Profile

Financial Performance

In 2024, Jiangsu Nanfang Medical's revenue was 602.62 million, an increase of 0.42% compared to the previous year's 600.10 million. Losses were -190.67 million, 29.3% more than in 2023.

Financial Statements

News

There is no news available yet.